Patients News | pharmaphorum

News

Shares in BridgeBio rose after it revealed data from a trial of infigratinib in achondroplasia, raising the prospect of the first oral treatment.

News

The UK government has asked the NHS to start putting together the platforms to allow anonymised primary care patient data to be used by researchers.

News

The FDA said it needs more information before it can approve Regenxbio's gene therapy for Hunter syndrome, in a devastating decision for patients.

News

The Trump administration's long-promised direct-to-consumer (DTC) sales channel for medicines, TrumpRx, has finally gone live.

News

A wireless sensor the size of a paperclip, Abbott's CardioMEMS HF, can now be used routinely by the NHS to monitor patients with heart failure.

News

The UK confirms that the cost of the drug pricing deal with the US, initially around £1bn over three years, will be borne by the health department.